GlassScriptPhysician profile
Joseph C Zola
NPI 1790973915
$3,817.40
in general payments reported to CMS, 2019-2025
37 companies · $915 in 2025
The $915 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $191 · 2021: $29.64 · 2022: $99.51 · 2023: $713 · 2024: $1,149 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,688 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,687.67 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $581.61 | 2019-2025 | Erleada, Akeega, Abiraterone Acetate |
| Astellas Pharma US INC | $540.31 | 2019-2024 | Xtandi |
| Sumitomo Pharma America, INC. | $521.47 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $296.22 | 2019-2025 | |
| Teleflex LLC | $168.64 | 2021-2025 | Urolift, Barrigel |
| Bayer Healthcare Pharmaceuticals INC. | $165.24 | 2024-2025 | |
| Procept Biorobotics Corporation | $160.30 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Endo Pharmaceuticals INC. | $125.93 | 2019-2024 | Xiaflex, Aveed |
| Laborie Medical Technologies Corp. | $123.93 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $97.44 | 2023-2025 | Itind System |
| Medtronic, INC. | $91.50 | 2024-2025 | Interstim, Altaviva |
| Endo USA, INC. | $87.77 | 2024-2025 | Xiaflex |
| Coloplast Corp | $73.17 | 2025 | |
| Aytu Biopharma, INC. | $72.66 | 2019-2020 | |
| Axonics, INC. | $72.08 | 2023-2024 | Axonics |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $66.33 | 2024-2025 | Eligard, Jatenzo |
| Convatec INC. | $62.81 | 2024-2025 | |
| Abc Home Medical Supply, INC. | $47.21 | 2025 | |
| Cycle Pharmaceuticals INC | $44.28 | 2025 | Venxxiva |
| Allergan, INC. | $41.83 | 2019-2020 | |
| Antares Pharma, INC. | $35.36 | 2019-2020 | |
| Boston Scientific Corporation | $32.30 | 2023-2025 | Axonics, Rezum Generator |
| Photonicare INC | $32.06 | 2025 | Otosight Middle Ear Scope |
| Smith+Nephew, INC. | $30.80 | 2019-2023 | Oasis, Stravix, Grafix Pl |
| Inspire Medical Systems, INC. | $27.81 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $27.52 | 2024 | |
| Ethicon US, LLC | $25.49 | 2019 | |
| Abbvie INC. | $24.76 | 2019 | |
| Calyxo, INC. | $24.00 | 2024 | Cvac Aspiration System |
| Halozyme INC | $20.08 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $19.92 | 2019 | |
| Dendreon Pharmaceuticals LLC | $13.86 | 2025 | Provenge |
| Merck Sharp & Dohme LLC | $13.39 | 2020 | |
| Davol INC. | $13.22 | 2020 | |
| Clarus Therapeutics INC. | $12.77 | 2021 | |
| Urovant Sciences INC | $12.52 | 2022 | |
| Tei Biosciences INC | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Zola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.